JMP Securities Reaffirms “Market Outperform” Rating for HealthEquity (NASDAQ:HQY)

JMP Securities reaffirmed their market outperform rating on shares of HealthEquity (NASDAQ:HQY) in a research report released on Wednesday morning, Benzinga reports. The brokerage currently has a $105.00 target price on the stock.

HQY has been the subject of several other research reports. Robert W. Baird increased their target price on HealthEquity from $98.00 to $104.00 and gave the stock an outperform rating in a research report on Tuesday, June 4th. Barrington Research reiterated an outperform rating and set a $105.00 price objective on shares of HealthEquity in a research report on Friday, August 30th. KeyCorp upped their target price on shares of HealthEquity from $95.00 to $100.00 and gave the stock an overweight rating in a research report on Wednesday, June 5th. Royal Bank of Canada reiterated an outperform rating and issued a $92.00 price target on shares of HealthEquity in a report on Wednesday. Finally, Raymond James increased their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the company an outperform rating in a report on Friday, June 7th. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of Moderate Buy and a consensus price target of $103.83.

HealthEquity Trading Down 4.1 %

Shares of HealthEquity stock opened at $76.24 on Wednesday. HealthEquity has a fifty-two week low of $61.81 and a fifty-two week high of $88.26. The company has a debt-to-equity ratio of 0.44, a quick ratio of 4.39 and a current ratio of 4.39. The company has a market capitalization of $6.63 billion, a P/E ratio of 82.87, a P/E/G ratio of 1.34 and a beta of 0.52. The company has a fifty day moving average of $77.03 and a 200 day moving average of $79.66.

Insider Activity

In related news, CEO Jon Kessler sold 32,326 shares of the firm’s stock in a transaction on Monday, June 24th. The stock was sold at an average price of $82.83, for a total value of $2,677,562.58. Following the completion of the sale, the chief executive officer now directly owns 232,176 shares in the company, valued at $19,231,138.08. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, CEO Jon Kessler sold 32,326 shares of the stock in a transaction dated Monday, June 24th. The shares were sold at an average price of $82.83, for a total value of $2,677,562.58. Following the sale, the chief executive officer now directly owns 232,176 shares of the company’s stock, valued at approximately $19,231,138.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Frank Corvino sold 7,705 shares of the firm’s stock in a transaction dated Monday, July 8th. The stock was sold at an average price of $81.89, for a total transaction of $630,962.45. Following the completion of the sale, the director now directly owns 6,070 shares of the company’s stock, valued at approximately $497,072.30. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 75,031 shares of company stock valued at $6,103,625. 2.20% of the stock is currently owned by insiders.

Institutional Trading of HealthEquity

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Cape Investment Advisory Inc. bought a new position in shares of HealthEquity in the fourth quarter worth about $27,000. Rise Advisors LLC bought a new position in HealthEquity in the 1st quarter worth about $28,000. International Assets Investment Management LLC purchased a new position in shares of HealthEquity during the second quarter worth approximately $35,000. YHB Investment Advisors Inc. bought a new stake in shares of HealthEquity during the first quarter valued at approximately $40,000. Finally, Fidelis Capital Partners LLC purchased a new stake in shares of HealthEquity in the first quarter valued at approximately $42,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.